National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Smoking Cessation and Continued Risk in Cancer Patients (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 01/09/2008
Nicotine Lozenges

  Brand  Dose  Side Effects  Comments 
OTC = over the counter.
OTC Commit 40–80 mg/day Local irritation (warmth and tingling) Use for 12 weeks; max 20 pieces/day. Weeks 1–6: 1–2 lozenges every 1–2 hours; weeks 7–9: 1 lozenge every 2–4 hours; weeks 10–12: 1 lozenge every 4–8 hours.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov